New eye drops aim to soothe dry eye inflammation
NCT ID NCT07245836
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether Thealoz Total eye drops can reduce inflammation and improve symptoms in people with chronic dry eye disease. The drops contain hyaluronic acid for lubrication, plus trehalose and NAAGA to fight inflammation. The trial planned to enroll 30 adults with moderate to severe dry eye, but it was terminated early.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Thealoz Total eye drops (hyaluronic acid, trehalose, and NAAGA)
- What this could lead to
- If it works, this could offer a new way to reduce inflammation and improve comfort for people with chronic dry eye.
- What could go wrong
- This was a small, early-terminated Phase 4 trial with only 30 participants. Results may not be reliable or apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Clinical Pharmacology, Medical University of Vienna, Austria
Vienna, State of Vienna, 1090, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can acne drug harm the eyes? new study investigates
- Which eye drop wins the dry eye battle? a Head-to-Head test
- Can a new eye drop soothe dry eye? a trial puts TRYPTYR to the test
- New eye drop aims to soothe dryness after cataract surgery
- Can simple eye drops soothe dry eyes? new study puts OTC brands to the test
- New eye drop hopes to soothe dry eye sufferers